Found 81 hits Enz. Inhib. hit(s) with all data for entry = 50032723 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333737
(3-(4-(2-(2-(2-methoxyphenyl)acetamido)ethyl)phenyl...)Show SMILES COc1ccccc1CC(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C30H32N2O3S/c1-19-16-20(2)28-24(17-19)27(29(36-28)30(34)32(3)4)22-12-10-21(11-13-22)14-15-31-26(33)18-23-8-6-7-9-25(23)35-5/h6-13,16-17H,14-15,18H2,1-5H3,(H,31,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333727
(3-(4-((N-(1-(2-methoxyphenyl)cyclopropanecarbonyl)...)Show SMILES COc1ccccc1C1(CC1)C(=O)NS(=O)(=O)Cc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C31H32N2O5S2/c1-19-16-20(2)27-23(17-19)26(28(39-27)29(34)33(3)4)22-12-10-21(11-13-22)18-40(36,37)32-30(35)31(14-15-31)24-8-6-7-9-25(24)38-5/h6-13,16-17H,14-15,18H2,1-5H3,(H,32,35) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.330 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333725
(3-(4-(2-(3-(4-chlorophenylsulfonyl)ureido)ethyl)ph...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C28H28ClN3O4S2/c1-17-15-18(2)25-23(16-17)24(26(37-25)27(33)32(3)4)20-7-5-19(6-8-20)13-14-30-28(34)31-38(35,36)22-11-9-21(29)10-12-22/h5-12,15-16H,13-14H2,1-4H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333731
(CHEMBL1644010 | N-(4-(5,7-dimethyl-2-(pyrrolidine-...)Show SMILES Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N1CCCC1 Show InChI InChI=1S/C31H33N3O4S2/c1-20-6-12-25(13-7-20)40(37,38)33-31(36)32-15-14-23-8-10-24(11-9-23)27-26-19-21(2)18-22(3)28(26)39-29(27)30(35)34-16-4-5-17-34/h6-13,18-19H,4-5,14-17H2,1-3H3,(H2,32,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.410 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333726
(3-(4-(2-(3-(2-chlorophenylsulfonyl)ureido)ethyl)ph...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccccc2Cl)cc1 Show InChI InChI=1S/C28H28ClN3O4S2/c1-17-15-18(2)25-21(16-17)24(26(37-25)27(33)32(3)4)20-11-9-19(10-12-20)13-14-30-28(34)31-38(35,36)23-8-6-5-7-22(23)29/h5-12,15-16H,13-14H2,1-4H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.420 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333728
(3-(4-((N-(1-(2,6-dichlorophenyl)cyclopropanecarbon...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CS(=O)(=O)NC(=O)C2(CC2)c2c(Cl)cccc2Cl)cc1 Show InChI InChI=1S/C30H28Cl2N2O4S2/c1-17-14-18(2)26-21(15-17)24(27(39-26)28(35)34(3)4)20-10-8-19(9-11-20)16-40(37,38)33-29(36)30(12-13-30)25-22(31)6-5-7-23(25)32/h5-11,14-15H,12-13,16H2,1-4H3,(H,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.440 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333730
(CHEMBL1644009 | N,5,7-trimethyl-3-(4-(2-(3-tosylur...)Show SMILES CNC(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C28H29N3O4S2/c1-17-5-11-22(12-6-17)37(34,35)31-28(33)30-14-13-20-7-9-21(10-8-20)24-23-16-18(2)15-19(3)25(23)36-26(24)27(32)29-4/h5-12,15-16H,13-14H2,1-4H3,(H,29,32)(H2,30,31,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333733
(5,7-difluoro-N,N-dimethyl-3-(4-(2-(3-tosylureido)e...)Show SMILES CN(C)C(=O)c1sc2c(F)cc(F)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C27H25F2N3O4S2/c1-16-4-10-20(11-5-16)38(35,36)31-27(34)30-13-12-17-6-8-18(9-7-17)23-21-14-19(28)15-22(29)24(21)37-25(23)26(33)32(2)3/h4-11,14-15H,12-13H2,1-3H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.530 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333748
(CHEMBL1644003 | N,N,5,7-tetramethyl-3-(4-(2-(3-tos...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C29H31N3O4S2/c1-18-6-12-23(13-7-18)38(35,36)31-29(34)30-15-14-21-8-10-22(11-9-21)25-24-17-19(2)16-20(3)26(24)37-27(25)28(33)32(4)5/h6-13,16-17H,14-15H2,1-5H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.540 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333734
(7-chloro-N,N-dimethyl-3-(4-(2-(3-tosylureido)ethyl...)Show SMILES CN(C)C(=O)c1sc2c(Cl)cc(cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1)C(F)(F)F Show InChI InChI=1S/C28H25ClF3N3O4S2/c1-16-4-10-20(11-5-16)41(38,39)34-27(37)33-13-12-17-6-8-18(9-7-17)23-21-14-19(28(30,31)32)15-22(29)24(21)40-25(23)26(36)35(2)3/h4-11,14-15H,12-13H2,1-3H3,(H2,33,34,37) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.550 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333732
(5,7-dichloro-N,N-dimethyl-3-(4-(2-(3-tosylureido)e...)Show SMILES CN(C)C(=O)c1sc2c(Cl)cc(Cl)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C27H25Cl2N3O4S2/c1-16-4-10-20(11-5-16)38(35,36)31-27(34)30-13-12-17-6-8-18(9-7-17)23-21-14-19(28)15-22(29)24(21)37-25(23)26(33)32(2)3/h4-11,14-15H,12-13H2,1-3H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.590 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333735
(CHEMBL1644014 | N,N,4,7-tetramethyl-3-(4-(2-(3-tos...)Show SMILES CN(C)C(=O)c1sc2c(C)ccc(C)c2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C29H31N3O4S2/c1-18-6-14-23(15-7-18)38(35,36)31-29(34)30-17-16-21-10-12-22(13-11-21)25-24-19(2)8-9-20(3)26(24)37-27(25)28(33)32(4)5/h6-15H,16-17H2,1-5H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.770 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333747
(CHEMBL1644002 | methyl 5,7-dimethyl-3-(4-(2-(3-tos...)Show SMILES COC(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C28H28N2O5S2/c1-17-5-11-22(12-6-17)37(33,34)30-28(32)29-14-13-20-7-9-21(10-8-20)24-23-16-18(2)15-19(3)25(23)36-26(24)27(31)35-4/h5-12,15-16H,13-14H2,1-4H3,(H2,29,30,32) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 0.970 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333741
(CHEMBL1644020 | N,N,5,7-tetramethyl-3-(4-(2-(pyrim...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNc2ncccn2)cc1 Show InChI InChI=1S/C25H26N4OS/c1-16-14-17(2)22-20(15-16)21(23(31-22)24(30)29(3)4)19-8-6-18(7-9-19)10-13-28-25-26-11-5-12-27-25/h5-9,11-12,14-15H,10,13H2,1-4H3,(H,26,27,28) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 0.980 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333743
(3-(4-((2H-tetrazol-5-yl)methyl)phenyl)-N,N,5,7-tet...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(Cc2nnn[nH]2)cc1 Show InChI InChI=1S/C21H21N5OS/c1-12-9-13(2)19-16(10-12)18(20(28-19)21(27)26(3)4)15-7-5-14(6-8-15)11-17-22-24-25-23-17/h5-10H,11H2,1-4H3,(H,22,23,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333748
(CHEMBL1644003 | N,N,5,7-tetramethyl-3-(4-(2-(3-tos...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C29H31N3O4S2/c1-18-6-12-23(13-7-18)38(35,36)31-29(34)30-15-14-21-8-10-22(11-9-21)25-24-17-19(2)16-20(3)26(24)37-27(25)28(33)32(4)5/h6-13,16-17H,14-15H2,1-5H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333740
(3-(4-(2-(2-(2,6-dichlorophenyl)acetamido)ethyl)phe...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)Cc2c(Cl)cccc2Cl)cc1 Show InChI InChI=1S/C29H28Cl2N2O2S/c1-17-14-18(2)27-22(15-17)26(28(36-27)29(35)33(3)4)20-10-8-19(9-11-20)12-13-32-25(34)16-21-23(30)6-5-7-24(21)31/h5-11,14-15H,12-13,16H2,1-4H3,(H,32,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333742
(CHEMBL1643997 | methyl 3-(4-((2H-tetrazol-5-yl)met...)Show SMILES COC(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(Cc2nnn[nH]2)cc1 Show InChI InChI=1S/C20H18N4O2S/c1-11-8-12(2)18-15(9-11)17(19(27-18)20(25)26-3)14-6-4-13(5-7-14)10-16-21-23-24-22-16/h4-9H,10H2,1-3H3,(H,21,22,23,24) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 1.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333725
(3-(4-(2-(3-(4-chlorophenylsulfonyl)ureido)ethyl)ph...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C28H28ClN3O4S2/c1-17-15-18(2)25-23(16-17)24(26(37-25)27(33)32(3)4)20-7-5-19(6-8-20)13-14-30-28(34)31-38(35,36)22-11-9-21(29)10-12-22/h5-12,15-16H,13-14H2,1-4H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333738
(CHEMBL1644017 | N,N,5,7-tetramethyl-3-(4-(2-(2-(py...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)Cc2ccccn2)cc1 Show InChI InChI=1S/C28H29N3O2S/c1-18-15-19(2)26-23(16-18)25(27(34-26)28(33)31(3)4)21-10-8-20(9-11-21)12-14-30-24(32)17-22-7-5-6-13-29-22/h5-11,13,15-16H,12,14,17H2,1-4H3,(H,30,32) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333748
(CHEMBL1644003 | N,N,5,7-tetramethyl-3-(4-(2-(3-tos...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C29H31N3O4S2/c1-18-6-12-23(13-7-18)38(35,36)31-29(34)30-15-14-21-8-10-22(11-9-21)25-24-17-19(2)16-20(3)26(24)37-27(25)28(33)32(4)5/h6-13,16-17H,14-15H2,1-5H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333726
(3-(4-(2-(3-(2-chlorophenylsulfonyl)ureido)ethyl)ph...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccccc2Cl)cc1 Show InChI InChI=1S/C28H28ClN3O4S2/c1-17-15-18(2)25-21(16-17)24(26(37-25)27(33)32(3)4)20-11-9-19(10-12-20)13-14-30-28(34)31-38(35,36)23-8-6-5-7-22(23)29/h5-12,15-16H,13-14H2,1-4H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 2.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333739
(3-(4-(2-(1-(2-methoxyphenyl)cyclopropanecarboxamid...)Show SMILES COc1ccccc1C1(CC1)C(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C32H34N2O3S/c1-20-18-21(2)28-24(19-20)27(29(38-28)30(35)34(3)4)23-12-10-22(11-13-23)14-17-33-31(36)32(15-16-32)25-8-6-7-9-26(25)37-5/h6-13,18-19H,14-17H2,1-5H3,(H,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333737
(3-(4-(2-(2-(2-methoxyphenyl)acetamido)ethyl)phenyl...)Show SMILES COc1ccccc1CC(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C30H32N2O3S/c1-19-16-20(2)28-24(17-19)27(29(36-28)30(34)32(3)4)22-12-10-21(11-13-22)14-15-31-26(33)18-23-8-6-7-9-25(23)35-5/h6-13,16-17H,14-15,18H2,1-5H3,(H,31,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333729
(5,7-dimethyl-3-(4-(2-(3-tosylureido)ethyl)phenyl)b...)Show SMILES Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(N)=O Show InChI InChI=1S/C27H27N3O4S2/c1-16-4-10-21(11-5-16)36(33,34)30-27(32)29-13-12-19-6-8-20(9-7-19)23-22-15-17(2)14-18(3)24(22)35-25(23)26(28)31/h4-11,14-15H,12-13H2,1-3H3,(H2,28,31)(H2,29,30,32) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 3.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333727
(3-(4-((N-(1-(2-methoxyphenyl)cyclopropanecarbonyl)...)Show SMILES COc1ccccc1C1(CC1)C(=O)NS(=O)(=O)Cc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C31H32N2O5S2/c1-19-16-20(2)27-23(17-19)26(28(39-27)29(34)33(3)4)22-12-10-21(11-13-22)18-40(36,37)32-30(35)31(14-15-31)24-8-6-7-9-25(24)38-5/h6-13,16-17H,14-15,18H2,1-5H3,(H,32,35) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 5.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333728
(3-(4-((N-(1-(2,6-dichlorophenyl)cyclopropanecarbon...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CS(=O)(=O)NC(=O)C2(CC2)c2c(Cl)cccc2Cl)cc1 Show InChI InChI=1S/C30H28Cl2N2O4S2/c1-17-14-18(2)26-21(15-17)24(27(39-26)28(35)34(3)4)20-10-8-19(9-11-20)16-40(37,38)33-29(36)30(12-13-30)25-22(31)6-5-7-23(25)32/h5-11,14-15H,12-13,16H2,1-4H3,(H,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 5.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333725
(3-(4-(2-(3-(4-chlorophenylsulfonyl)ureido)ethyl)ph...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C28H28ClN3O4S2/c1-17-15-18(2)25-23(16-17)24(26(37-25)27(33)32(3)4)20-7-5-19(6-8-20)13-14-30-28(34)31-38(35,36)22-11-9-21(29)10-12-22/h5-12,15-16H,13-14H2,1-4H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 5.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333739
(3-(4-(2-(1-(2-methoxyphenyl)cyclopropanecarboxamid...)Show SMILES COc1ccccc1C1(CC1)C(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C32H34N2O3S/c1-20-18-21(2)28-24(19-20)27(29(38-28)30(35)34(3)4)23-12-10-22(11-13-23)14-17-33-31(36)32(15-16-32)25-8-6-7-9-26(25)37-5/h6-13,18-19H,14-17H2,1-5H3,(H,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 5.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333726
(3-(4-(2-(3-(2-chlorophenylsulfonyl)ureido)ethyl)ph...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccccc2Cl)cc1 Show InChI InChI=1S/C28H28ClN3O4S2/c1-17-15-18(2)25-21(16-17)24(26(37-25)27(33)32(3)4)20-11-9-19(10-12-20)13-14-30-28(34)31-38(35,36)23-8-6-5-7-22(23)29/h5-12,15-16H,13-14H2,1-4H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 6.40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333734
(7-chloro-N,N-dimethyl-3-(4-(2-(3-tosylureido)ethyl...)Show SMILES CN(C)C(=O)c1sc2c(Cl)cc(cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1)C(F)(F)F Show InChI InChI=1S/C28H25ClF3N3O4S2/c1-16-4-10-20(11-5-16)41(38,39)34-27(37)33-13-12-17-6-8-18(9-7-17)23-21-14-19(28(30,31)32)15-22(29)24(21)40-25(23)26(36)35(2)3/h4-11,14-15H,12-13H2,1-3H3,(H2,33,34,37) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 8.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333746
(3-(4-(2-(dimethylcarbamoyl)-5,7-dimethylbenzo[b]th...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C22H23NO3S/c1-13-11-14(2)20-17(12-13)19(21(27-20)22(26)23(3)4)16-8-5-15(6-9-16)7-10-18(24)25/h5-6,8-9,11-12H,7,10H2,1-4H3,(H,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333740
(3-(4-(2-(2-(2,6-dichlorophenyl)acetamido)ethyl)phe...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)Cc2c(Cl)cccc2Cl)cc1 Show InChI InChI=1S/C29H28Cl2N2O2S/c1-17-14-18(2)27-22(15-17)26(28(36-27)29(35)33(3)4)20-10-8-19(9-11-20)12-13-32-25(34)16-21-23(30)6-5-7-24(21)31/h5-11,14-15H,12-13,16H2,1-4H3,(H,32,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333731
(CHEMBL1644010 | N-(4-(5,7-dimethyl-2-(pyrrolidine-...)Show SMILES Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N1CCCC1 Show InChI InChI=1S/C31H33N3O4S2/c1-20-6-12-25(13-7-20)40(37,38)33-31(36)32-15-14-23-8-10-24(11-9-23)27-26-19-21(2)18-22(3)28(26)39-29(27)30(35)34-16-4-5-17-34/h6-13,18-19H,4-5,14-17H2,1-3H3,(H2,32,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333728
(3-(4-((N-(1-(2,6-dichlorophenyl)cyclopropanecarbon...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CS(=O)(=O)NC(=O)C2(CC2)c2c(Cl)cccc2Cl)cc1 Show InChI InChI=1S/C30H28Cl2N2O4S2/c1-17-14-18(2)26-21(15-17)24(27(39-26)28(35)34(3)4)20-10-8-19(9-11-20)16-40(37,38)33-29(36)30(12-13-30)25-22(31)6-5-7-23(25)32/h5-11,14-15H,12-13,16H2,1-4H3,(H,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333744
(3-(4-(2H-tetrazol-5-yl)phenyl)-N,N,5,7-tetramethyl...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(cc1)-c1nnn[nH]1 Show InChI InChI=1S/C20H19N5OS/c1-11-9-12(2)17-15(10-11)16(18(27-17)20(26)25(3)4)13-5-7-14(8-6-13)19-21-23-24-22-19/h5-10H,1-4H3,(H,21,22,23,24) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333727
(3-(4-((N-(1-(2-methoxyphenyl)cyclopropanecarbonyl)...)Show SMILES COc1ccccc1C1(CC1)C(=O)NS(=O)(=O)Cc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C31H32N2O5S2/c1-19-16-20(2)27-23(17-19)26(28(39-27)29(34)33(3)4)22-12-10-21(11-13-22)18-40(36,37)32-30(35)31(14-15-31)24-8-6-7-9-25(24)38-5/h6-13,16-17H,14-15,18H2,1-5H3,(H,32,35) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333734
(7-chloro-N,N-dimethyl-3-(4-(2-(3-tosylureido)ethyl...)Show SMILES CN(C)C(=O)c1sc2c(Cl)cc(cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1)C(F)(F)F Show InChI InChI=1S/C28H25ClF3N3O4S2/c1-16-4-10-20(11-5-16)41(38,39)34-27(37)33-13-12-17-6-8-18(9-7-17)23-21-14-19(28(30,31)32)15-22(29)24(21)40-25(23)26(36)35(2)3/h4-11,14-15H,12-13H2,1-3H3,(H2,33,34,37) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333738
(CHEMBL1644017 | N,N,5,7-tetramethyl-3-(4-(2-(2-(py...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)Cc2ccccn2)cc1 Show InChI InChI=1S/C28H29N3O2S/c1-18-15-19(2)26-23(16-18)25(27(34-26)28(33)31(3)4)21-10-8-20(9-11-21)12-14-30-24(32)17-22-7-5-6-13-29-22/h5-11,13,15-16H,12,14,17H2,1-4H3,(H,30,32) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333737
(3-(4-(2-(2-(2-methoxyphenyl)acetamido)ethyl)phenyl...)Show SMILES COc1ccccc1CC(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C30H32N2O3S/c1-19-16-20(2)28-24(17-19)27(29(36-28)30(34)32(3)4)22-12-10-21(11-13-22)14-15-31-26(33)18-23-8-6-7-9-25(23)35-5/h6-13,16-17H,14-15,18H2,1-5H3,(H,31,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333740
(3-(4-(2-(2-(2,6-dichlorophenyl)acetamido)ethyl)phe...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCNC(=O)Cc2c(Cl)cccc2Cl)cc1 Show InChI InChI=1S/C29H28Cl2N2O2S/c1-17-14-18(2)27-22(15-17)26(28(36-27)29(35)33(3)4)20-10-8-19(9-11-20)12-13-32-25(34)16-21-23(30)6-5-7-24(21)31/h5-11,14-15H,12-13,16H2,1-4H3,(H,32,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333732
(5,7-dichloro-N,N-dimethyl-3-(4-(2-(3-tosylureido)e...)Show SMILES CN(C)C(=O)c1sc2c(Cl)cc(Cl)cc2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C27H25Cl2N3O4S2/c1-16-4-10-20(11-5-16)38(35,36)31-27(34)30-13-12-17-6-8-18(9-7-17)23-21-14-19(28)15-22(29)24(21)37-25(23)26(33)32(2)3/h4-11,14-15H,12-13H2,1-3H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333739
(3-(4-(2-(1-(2-methoxyphenyl)cyclopropanecarboxamid...)Show SMILES COc1ccccc1C1(CC1)C(=O)NCCc1ccc(cc1)-c1c(sc2c(C)cc(C)cc12)C(=O)N(C)C Show InChI InChI=1S/C32H34N2O3S/c1-20-18-21(2)28-24(19-20)27(29(38-28)30(35)34(3)4)23-12-10-22(11-13-23)14-17-33-31(36)32(15-16-32)25-8-6-7-9-26(25)37-5/h6-13,18-19H,14-17H2,1-5H3,(H,33,36) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333735
(CHEMBL1644014 | N,N,4,7-tetramethyl-3-(4-(2-(3-tos...)Show SMILES CN(C)C(=O)c1sc2c(C)ccc(C)c2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C29H31N3O4S2/c1-18-6-14-23(15-7-18)38(35,36)31-29(34)30-17-16-21-10-12-22(13-11-21)25-24-19(2)8-9-20(3)26(24)37-27(25)28(33)32(4)5/h6-15H,16-17H2,1-5H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333745
(3-(4-(2-(2H-tetrazol-5-yl)ethyl)phenyl)-N,N,5,7-te...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCc2nnn[nH]2)cc1 Show InChI InChI=1S/C22H23N5OS/c1-13-11-14(2)20-17(12-13)19(21(29-20)22(28)27(3)4)16-8-5-15(6-9-16)7-10-18-23-25-26-24-18/h5-6,8-9,11-12H,7,10H2,1-4H3,(H,23,24,25,26) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333743
(3-(4-((2H-tetrazol-5-yl)methyl)phenyl)-N,N,5,7-tet...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(Cc2nnn[nH]2)cc1 Show InChI InChI=1S/C21H21N5OS/c1-12-9-13(2)19-16(10-12)18(20(28-19)21(27)26(3)4)15-7-5-14(6-8-15)11-17-22-24-25-23-17/h5-10H,11H2,1-4H3,(H,22,23,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333735
(CHEMBL1644014 | N,N,4,7-tetramethyl-3-(4-(2-(3-tos...)Show SMILES CN(C)C(=O)c1sc2c(C)ccc(C)c2c1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1 Show InChI InChI=1S/C29H31N3O4S2/c1-18-6-14-23(15-7-18)38(35,36)31-29(34)30-17-16-21-10-12-22(13-11-21)25-24-19(2)8-9-20(3)26(24)37-27(25)28(33)32(4)5/h6-15H,16-17H2,1-5H3,(H2,30,31,34) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333745
(3-(4-(2-(2H-tetrazol-5-yl)ethyl)phenyl)-N,N,5,7-te...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCc2nnn[nH]2)cc1 Show InChI InChI=1S/C22H23N5OS/c1-13-11-14(2)20-17(12-13)19(21(29-20)22(28)27(3)4)16-8-5-15(6-9-16)7-10-18-23-25-26-24-18/h5-6,8-9,11-12H,7,10H2,1-4H3,(H,23,24,25,26) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333743
(3-(4-((2H-tetrazol-5-yl)methyl)phenyl)-N,N,5,7-tet...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(Cc2nnn[nH]2)cc1 Show InChI InChI=1S/C21H21N5OS/c1-12-9-13(2)19-16(10-12)18(20(28-19)21(27)26(3)4)15-7-5-14(6-8-15)11-17-22-24-25-23-17/h5-10H,11H2,1-4H3,(H,22,23,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Binding affinity to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |
Prostaglandin E2 receptor EP4 subtype
(Homo sapiens (Human)) | BDBM50333746
(3-(4-(2-(dimethylcarbamoyl)-5,7-dimethylbenzo[b]th...)Show SMILES CN(C)C(=O)c1sc2c(C)cc(C)cc2c1-c1ccc(CCC(O)=O)cc1 Show InChI InChI=1S/C22H23NO3S/c1-13-11-14(2)20-17(12-13)19(21(27-20)22(26)23(3)4)16-8-5-15(6-9-16)7-10-18(24)25/h5-6,8-9,11-12H,7,10H2,1-4H3,(H,24,25) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Centre for Therapeutic Research
Curated by ChEMBL
| Assay Description Ratio of Ki for EP4 receptor to EP4 receptor in presence of 10% HSA |
Bioorg Med Chem Lett 21: 734-7 (2011)
Article DOI: 10.1016/j.bmcl.2010.11.118 BindingDB Entry DOI: 10.7270/Q22N52JP |
More data for this Ligand-Target Pair | |